Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylene Blue for Cognitive Dysfunction in Bipolar Disorder
NCT00214877Phase 3Completed
- Sponsor
- Nova Scotia Health
- Start
- Nov 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of methylene blue in bipolar disorder (BD), sponsored by Nova Scotia Health. Started Nov 2003; status: completed.
02
Drugs
methylene blue
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on NCT00214877.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00214877.